Cargando…

Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies

BACKGROUND: The composition of the tumor microenvironment (TME) is conditioned by immunity and the inflammatory response. Nutritional and inflammation-based risk scores have emerged as relevant predictors of survival outcome across a variety of hematological malignancies. METHODS: In this retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebauer, Niklas, Mengler, Britta, Kopelke, Svenja, Frydrychowicz, Alex, Fürschke, Alexander, Hackenbroch, Carsten, Bauer, Arthur, Riecke, Armin, von Bubnoff, Nikolaus, Fetscher, Sebastian, Witte, Hanno M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189087/
https://www.ncbi.nlm.nih.gov/pubmed/34415426
http://dx.doi.org/10.1007/s00432-021-03758-5
_version_ 1784725506536505344
author Gebauer, Niklas
Mengler, Britta
Kopelke, Svenja
Frydrychowicz, Alex
Fürschke, Alexander
Hackenbroch, Carsten
Bauer, Arthur
Riecke, Armin
von Bubnoff, Nikolaus
Fetscher, Sebastian
Witte, Hanno M.
author_facet Gebauer, Niklas
Mengler, Britta
Kopelke, Svenja
Frydrychowicz, Alex
Fürschke, Alexander
Hackenbroch, Carsten
Bauer, Arthur
Riecke, Armin
von Bubnoff, Nikolaus
Fetscher, Sebastian
Witte, Hanno M.
author_sort Gebauer, Niklas
collection PubMed
description BACKGROUND: The composition of the tumor microenvironment (TME) is conditioned by immunity and the inflammatory response. Nutritional and inflammation-based risk scores have emerged as relevant predictors of survival outcome across a variety of hematological malignancies. METHODS: In this retrospective multicenter trial, we ascertained the prognostic impact of established nutritional and inflammation-based risk scores [Glasgow Prognostic Score (GPS), C-reactive–protein/albumin ratio (CAR), neutrophil–lymphocyte ratio (NLR), prognostic nutritional index (PNI), and prognostic index (PI)] in 209 eligible patients with histologically confirmed CD20(+) follicular lymphoma (FL) of WHO grade 1 (37.3%), 1–2 (16.3%), 2 (26.8%) or 3A (19.8%) admitted to the participating centers between January 2000 and December 2019. Characteristics significantly associated with overall or progression-free survival (OS, PFS) upon univariate analysis were subsequently included in a Cox proportional hazard model. RESULTS: In the study cohort, the median age was 63 (range 22–90 years). The median follow-up period covered 99 months. The GPS and the CAR were identified to predict survival in FL patients. The GPS was the only independent predictor of OS (p < 0.0001; HR 2.773; 95% CI 1.630–4.719) and PFS (p = 0.001; HR 1.995; 95% CI 1.352–2.944) upon multivariate analysis. Additionally, there was frequent occurrence of progression of disease within 24 months (POD24) in FL patients with a calculated GPS of 2. CONCLUSION: The current results indicate that the GPS predicts especially OS in FL patients. Moreover, GPS was found to display disease-specific effects in regard to FL progression. These findings and potential combinations with additional established prognosticators should be further validated within prospective clinical trials. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-021-03758-5.
format Online
Article
Text
id pubmed-9189087
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91890872022-06-14 Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies Gebauer, Niklas Mengler, Britta Kopelke, Svenja Frydrychowicz, Alex Fürschke, Alexander Hackenbroch, Carsten Bauer, Arthur Riecke, Armin von Bubnoff, Nikolaus Fetscher, Sebastian Witte, Hanno M. J Cancer Res Clin Oncol Original Article – Clinical Oncology BACKGROUND: The composition of the tumor microenvironment (TME) is conditioned by immunity and the inflammatory response. Nutritional and inflammation-based risk scores have emerged as relevant predictors of survival outcome across a variety of hematological malignancies. METHODS: In this retrospective multicenter trial, we ascertained the prognostic impact of established nutritional and inflammation-based risk scores [Glasgow Prognostic Score (GPS), C-reactive–protein/albumin ratio (CAR), neutrophil–lymphocyte ratio (NLR), prognostic nutritional index (PNI), and prognostic index (PI)] in 209 eligible patients with histologically confirmed CD20(+) follicular lymphoma (FL) of WHO grade 1 (37.3%), 1–2 (16.3%), 2 (26.8%) or 3A (19.8%) admitted to the participating centers between January 2000 and December 2019. Characteristics significantly associated with overall or progression-free survival (OS, PFS) upon univariate analysis were subsequently included in a Cox proportional hazard model. RESULTS: In the study cohort, the median age was 63 (range 22–90 years). The median follow-up period covered 99 months. The GPS and the CAR were identified to predict survival in FL patients. The GPS was the only independent predictor of OS (p < 0.0001; HR 2.773; 95% CI 1.630–4.719) and PFS (p = 0.001; HR 1.995; 95% CI 1.352–2.944) upon multivariate analysis. Additionally, there was frequent occurrence of progression of disease within 24 months (POD24) in FL patients with a calculated GPS of 2. CONCLUSION: The current results indicate that the GPS predicts especially OS in FL patients. Moreover, GPS was found to display disease-specific effects in regard to FL progression. These findings and potential combinations with additional established prognosticators should be further validated within prospective clinical trials. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-021-03758-5. Springer Berlin Heidelberg 2021-08-20 2022 /pmc/articles/PMC9189087/ /pubmed/34415426 http://dx.doi.org/10.1007/s00432-021-03758-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article – Clinical Oncology
Gebauer, Niklas
Mengler, Britta
Kopelke, Svenja
Frydrychowicz, Alex
Fürschke, Alexander
Hackenbroch, Carsten
Bauer, Arthur
Riecke, Armin
von Bubnoff, Nikolaus
Fetscher, Sebastian
Witte, Hanno M.
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
title Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
title_full Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
title_fullStr Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
title_full_unstemmed Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
title_short Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
title_sort prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-cd20 targeted treatment strategies
topic Original Article – Clinical Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189087/
https://www.ncbi.nlm.nih.gov/pubmed/34415426
http://dx.doi.org/10.1007/s00432-021-03758-5
work_keys_str_mv AT gebauerniklas prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT menglerbritta prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT kopelkesvenja prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT frydrychowiczalex prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT furschkealexander prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT hackenbrochcarsten prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT bauerarthur prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT rieckearmin prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT vonbubnoffnikolaus prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT fetschersebastian prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies
AT wittehannom prognosticimpactofnutritionalandinflammationbasedriskscoresinfollicularlymphomaintheeraofanticd20targetedtreatmentstrategies